| Literature DB >> 34446922 |
Leonora Balaj1, Chantal M Boulanger2, David R F Carter3,4, Ewoud B Compeer5, Gisela D'Angelo6, Samir El Andaloussi4,7, Jacky G Goetz8, Julia Christina Gross9, Vincent Hyenne8,10, Eva-Maria Krämer-Albers11, Charles P Lai12, Xavier Loyer2, Alex Marki13, Stefan Momma14, Esther N M Nolte-'t Hoen15, D Michiel Pegtel16, Hector Peinado17, Graça Raposo6, Kirsi Rilla18, Hidetoshi Tahara19, Clotilde Théry20, Martin E van Royen21, Roosmarijn E Vandenbroucke22, Ann M Wehman23, Kenneth Witwer24, Zhiwei Wu25,26,27, Richard Wubbolts15, Frederik J Verweij28,29, Guillaume van Niel30,31.
Abstract
Extracellular vesicles (EVs) are nano-sized lipid bilayer vesicles released by virtually every cell type. EVs have diverse biological activities, ranging from roles in development and homeostasis to cancer progression, which has spurred the development of EVs as disease biomarkers and drug nanovehicles. Owing to the small size of EVs, however, most studies have relied on isolation and biochemical analysis of bulk EVs separated from biofluids. Although informative, these approaches do not capture the dynamics of EV release, biodistribution, and other contributions to pathophysiology. Recent advances in live and high-resolution microscopy techniques, combined with innovative EV labeling strategies and reporter systems, provide new tools to study EVs in vivo in their physiological environment and at the single-vesicle level. Here we critically review the latest advances and challenges in EV imaging, and identify urgent, outstanding questions in our quest to unravel EV biology and therapeutic applications.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34446922 PMCID: PMC8796660 DOI: 10.1038/s41592-021-01206-3
Source DB: PubMed Journal: Nat Methods ISSN: 1548-7091 Impact factor: 28.547